Search Within

Population Sciences Research Program

Formats
  1. Journal Article (7256)
  2. Meeting Abstract (3358)
  3. Book Section (337)
  4. Review (306)
  5. Editorial (270)
  6. Research Letter (122)
  7. Correspondence (117)
  8. Conference Paper (67)
  9. Guidelines (60)
  10. Miscellaneous (45)
  11. Book Whole (24)
Groups
  1. Survivorship Research (5796)
  2. Department of Medicine (5281)
  3. Epidemiology and Biostatistics (5003)
  4. Solid Tumor Oncology Division (3412)
  5. Surgery (3039)
  6. Psychiatry and Behavioral Sciences, Department of (2830)

More Groups

People
  1. Andrew Vickers (898)
  2. Kenneth Offit (792)
  3. Mark Robson (684)
  4. Steven Horwitz (671)
  5. T Peter Kingham (629)
  6. Katherine Panageas (525)

More People

Years
  1. 2025 (444)
  2. 2024 (777)
  3. 2023 (819)
  4. 2022 (829)
  5. 2021 (784)
  6. 2020 (733)

More Years

Publications
  1. Journal of Clinical Oncology (1263)
  2. Blood (414)
  3. Psycho-Oncology (345)
  4. Cancer (245)
  5. Annals of Surgical Oncology (242)
  6. Cancer Research (234)

More Publications

Publishers
  1. American Society of Clinical Oncology (1442)
  2. Springer (1137)
  3. Elsevier Inc. (1079)
  4. Elsevier Science, Inc. (831)
  5. Oxford University Press (768)
  6. Wiley Blackwell (628)

More Publishers

Results (11962)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence of colonic neoplasia by age and indication in the GIQuIC national clinical registry
    Meeting Abstract

    Liang, P. S.; Williams, J. L.; Dominitz, J. A.; Corley, D. A.; Zauber, A. G.
    Gastrointestinal Endoscopy (2019)

    Fulltext@MSK | Save
  • A phase 1/1b dose-escalation trial evaluating CPI‐818, an oral interleukin‐2‐inducible T‐cell kinase inhibitor, in patients with relapsed/refractory T‐cell lymphoma
    Meeting Abstract

    Mobasher, M.; Miller, R.; Janc, J.; Kwei, L.; Barker, C.; Mohammady, A.; Luciano, G.; Radeski, D.; Kim, Y.; Khodadoust, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Response to brentuximab vedotin by CD30 expression: Results from five trials in PTCL, CTCL, and B‐cell lymphomas
    Meeting Abstract

    Jagadeesh, D.; Horwitz, S.; Bartlett, N. L.; Advani, R.; Jacobsen, E.; Duvic, M.; Gautman, A.; Rao, S.; Onsum, M.; Fanale, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Response to A+CHP by CD30 expression in the ECHELON‐2 trial
    Meeting Abstract

    Illidge, T.; Horwitz, S.; Iyer, S.; Bartlett, N.; Kim, W.; Tilly, H.; Belada, D.; Feldman, T.; Illés, Á; Jacobsen, E.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Anaplastic large cell lymphoma, ALK‐negative: Analysis of 235 cases collected by the T‐cell project
    Meeting Abstract

    Shustov, A.; Cabrera, M.; Bellei, M.; Civallero, M.; Ko, Y. H.; Manni, M.; Horwitz, S. M.; Antonio De Souza, C.; Radford, J.; Varela, S. B.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Final data from the phase 3 ALCANZA study: Brentuximab vedotin (BV) vs physician's choice (PC) in patients (PTS) with CD30‐positive (CD30+) cutaneous T‐cell lymphoma (CTCL)
    Meeting Abstract

    Horwitz, S. M.; Scarisbrick, J.; Prince, H. M.; Whittaker, S.; Duvic, M.; Kim, Y. H.; Quaglino, P.; Zinzani, P. L.; Bechter, O.; Eradat, H.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Phase I/II study of CHOEP plus lenalidomide as initial therapy for patients with stage II‐IV peripheral T‐cell lymphoma: Phase II results
    Meeting Abstract

    Lunning, M.; Horwitz, S.; Advani, R.; Vose, J.; Lee, H.; Mehta‐Shah, N.; Zain, J.; Haverkos, B.; Lechowicz, M.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Impact of pet imaging and histologic transformation on the prognosis of early disease progression in follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Hamlin, P.; Horwitz, S. M.; Kumar, A.; Matasar, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save